Line Uhrenholt - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Line Uhrenholt

This paper was not found in any repository, but could be made available legally by the author.

2023 Mikkel Østergaard

ORCID

, Ronald F. van Vollenhoven

ORCID

, Anna Rudin, Merete Lund Hetland

ORCID

, Marte Schrumpf Heiberg, Dan C. Nordström, Michael T. Nurmohamed

ORCID

, Bjorn Gudbjornsson, Lykke Midtbøll Ørnbjerg

ORCID

, Pernille Bøyesen, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig

ORCID

, Tuulikki Sokka

ORCID

, Gerdur Grondal and 30 other authors

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 Line Uhrenholt

ORCID

, Robin Christensen, Wilfred K. H. Dinesen, Caroline H. Liboriussen, Stine S. Andersen, Lene Dreyer, Annette Schlemmer, Ellen-Margrethe Hauge, Conni Skrubbeltrang, Peter C. Taylor

ORCID

, Salome Kristensen

Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 René Cordtz

ORCID

, Jesper Lindhardsen, Bolette G. Soussi, Jonathan Vela

ORCID

, Line Uhrenholt

ORCID

, Rasmus Westermann, Salome Kristensen, Henrik Nielsen, Christian Torp-Pedersen, Lene Dreyer

Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

Upload

This paper is made freely available by the publisher.

2019 Line Uhrenholt

ORCID

, Annette Schlemmer, Ellen-Margrethe Hauge, Robin Christensen, Lene Dreyer, Maria E. Suarez-Almazor, Salome Kristensen

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2018 Line Uhrenholt

ORCID

[Acute abdominal vasculitis in rheumatic diseases]

Upload

Missing publications? Search for publications with a matching author name.